Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Standard of Care 24Interviews as Topic 21Specimen Handling 19Educational Status 19Early Intervention, Educational 19Practice Guidelines as Topic 18Methods 17Exercise 17Surveys and Questionnaires 10Radiosurgery 10Magnetic Resonance Spectroscopy 10Palliative Care 9Patient Navigation 8Diet Therapy 8Blood Specimen Collection 8Counseling 7Surgical Procedures, Operative 5Radiotherapy 5Magnetic Resonance Imaging 5Genetic Testing 5Biopsy 5fludarabine 4Radiation Dose Hypofractionation 4Nutrition Assessment 4Mastectomy, Segmental 4Human Papillomavirus DNA Tests 4Health Promotion 4Dietary Supplements 4Diet, Ketogenic 4Colposcopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cystoscopy × 30 days × Clear all
NCT07180212 2026-05-11

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

Tianjin Medical University Second Hospital

Phase NA Recruiting
360 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡